Drug and vaccine authorizations for COVID-19: List of authorized drugs, vaccines and expanded indications

Date published: 2021-07-30

Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed here.

In the list below, the entry for each authorized drug and vaccine includes the:

In the "authorization" column, there are 4 possible scenarios for each drug or vaccine:

List of authorized drugs, vaccines and expanded indications for COVID-19
Authorization holder Brand name, proper name or common name Therapeutic area Control number Date of authorization or expanded indication Authorization or expanded indication
GlaxoSmithKline Inc Sotrovimab
Sotrovimab for injection
Immune sera and immunoglobulins, for human use 251285 2021-07-30 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
BioNTech Manufacturing GmbH Pfizer-BioNTech COVID-19 Vaccine Tozinameran (mRNA vaccine, BNT162b2) suspension for injection Vaccines, for human use 251730 2021-05-05

Pediatric indication (ages 12-15).

Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.

BioNTech Manufacturing GmbH Pfizer-BioNTech COVID-19 Vaccine
Tozinameran (mRNA vaccine, BNT162b2) suspension for injection
Vaccines, for human use 244906 2020-12-09 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
Gilead Sciences Canada Inc. Veklury
Remdesivir solution for injection
Antivirals for systemic use, for human use 240551 2020-07-27 Food and Drug Regulations. Issued Notice of Compliance under the NOC/c Guidance.
Eli Lilly Canada Inc Bamlanivimab
Bamlanivimab solution for injection
Immune sera and immunoglobulins, for human use 244947 2020-11-20 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
ModernaTX, Inc COVID-19 Vaccine Moderna
mRNA-1273 SARS-CoV-2
suspension for injection
Vaccines, for human use 244946 2020-12-23 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
AstraZeneca Canada Inc AstraZeneca COVID-19 Vaccine
ChAdOx1-S (recombinant)
solution for injection
Vaccines, for human use 244627 2021-02-26 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
Verity Pharmaceuticals Inc/Serum Institute of India (in partnership with AstraZeneca Canada Inc) Covishield
ChAdOx1-S (recombinant)
solution for injection
Vaccines, for human use 248651 2021-02-26 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
Janssen Inc Janssen COVID-19 Vaccine
AD26.COV2.S (recombinant)
suspension for injection
Vaccines, for human use 246758 2021-03-05 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
Hoffmann-La Roche Limited Casirivimab and imdevimab
Casirivimab and imdevimab solution for injection
Immune sera and immunoglobulins, for human use 249830 2021-06-09 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: